Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works

Untitled work

(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · see citing works

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67667-2 · Cited by 3,284 · see citing works

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · see citing works

Major lipids, apolipoproteins, and risk of vascular disease

The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Molecular mediators of hepatic steatosis and liver injury

Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772 · see citing works

Atherogenesis: a postprandial phenomenon.

Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585 · see citing works

Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications

Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399 · see citing works

Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association

Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000510 · Cited by 1,386 · see citing works

The LDL Receptor

Goldstein, J. L., & Brown, M. S. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179564 · Cited by 1,344 · see citing works

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.009 · Cited by 1,193 · see citing works

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116 · see citing works

Loss-of-Function Mutations in <i>APOC3,</i> Triglycerides, and Coronary Disease

The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071 · see citing works

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

Nicholls, S. J., Lincoff, A. M., Garcia, M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., et al. (2020) · JAMA · doi:10.1001/jama.2020.22258 · Cited by 1,028 · see citing works

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019 · see citing works

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Kotseva, K., Backer, G. D., Bacquer, D. D., Rydén, L., Hoes, A. W., Grobbee, D. E., Maggioni, A. P., Marques-Vidal, P. M., Jennings, C. S., Abreu, A., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318825350 · Cited by 940 · see citing works

Loss-of-Function Mutations in <i>APOC3</i> and Risk of Ischemic Vascular Disease

Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919 · see citing works

Diabetic dyslipidaemia: from basic research to clinical practice*

Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888 · see citing works

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885 · see citing works

Lipoprotein lipase: from gene to obesity

Wang, H., & Eckel, R. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90920.2008 · Cited by 862 · see citing works

Evinacumab for Homozygous Familial Hypercholesterolemia

Raal, F. J., Rosenson, R. S., Reeskamp, L. F., Hovingh, G. K., Kastelein, J. J. P., Rubba, P., Ali, S., Banerjee, P., Chan, K.-C., Gipe, D. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004215 · Cited by 793 · see citing works

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771 · see citing works

Exome Sequencing, <i>ANGPTL3</i> Mutations, and Familial Combined Hypolipidemia

Musunuru, K., Pirruccello, J. P., Do, R., Peloso, G. M., Guiducci, C., Sougnez, C., Garimella, K. V., Fisher, S., Abreu, J., Barry, A. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002926 · Cited by 754 · see citing works

Plasma triglyceride and coronary heart disease

Austin, M. A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.2 · Cited by 697 · see citing works

Overproduction of large VLDL particles is driven by increased liver fat content in man

Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0125-z · Cited by 690 · see citing works

Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment

Ceriello, A., Taboga, C., Tonutti, L., Quagliaro, L., Piconi, L., Bais, B., Da Ros, R., & Motz, E. (2002) · Circulation · doi:10.1161/01.cir.0000027569.76671.a8 · Cited by 655 · see citing works

Dysregulated lipid metabolism links NAFLD to cardiovascular disease

Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 558 · see citing works

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome

Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., Taskinen, M.-R., Ehnholm, C., Keech, A., & on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1543 · Cited by 551 · see citing works

Role of Estrogens in the Regulation of Liver Lipid Metabolism

Palmisano, B. T., Zhu, L., & Stafford, J. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_12 · Cited by 550 · see citing works

Physiological regulation of lipoprotein lipase

Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 548 · see citing works

Clinical review on triglycerides

Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544 · see citing works

Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3

Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539 · see citing works

Exome-wide association study of plasma lipids in >300,000 individuals

Charge Diabetes Working Group, Liu, D. J., Program, V. M. V., Peloso, G. M., Yu, H., Butterworth, A. S., Wang, X. Q., Mahajan, A., Saleheen, D., Emdin, C. A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3977 · Cited by 538 · see citing works

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

Lewis, G., Uffelman, K., Szeto, L., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 533 · see citing works

Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL

Romeo, S., Pennacchio, L. A., Fu, Y., Boerwinkle, E., Tybjaerg-Hansen, A., Hobbs, H. H., & Cohen, J. C. (2007) · Nature Genetics · doi:10.1038/ng1984 · Cited by 511 · see citing works

Hepatic uptake of chylomicron remnants

Cooper, A. D. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34932-4 · Cited by 499 · see citing works

Inactivating Variants in <i>ANGPTL4</i> and Risk of Coronary Artery Disease

Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497 · see citing works

Targeting APOC3 in the familial chylomicronemia syndrome

Gaudet, D., Brisson, D., Tremblay, K., Alexander, V. J., Singleton, W., Hughes, S. G., Geary, R. S., Baker, B. F., Graham, M. J., Crooke, R. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400284 · Cited by 491 · see citing works

Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons

Beigneux, A. P., Davies, B. S. J., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F. V., Jr., Bunting, S., Walzem, R. L., Wong, J. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.002 · Cited by 470 · see citing works

ANGPTL3 deficiency and protection against coronary artery disease

Stitziel, N. O., Khera, A. V., Wang, X., Bierhals, A. J., Vourakis, A. C., Sperry, A. E., Natarajan, P., Klarin, D., Emdin, C. A., Zekavat, S. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.030 · Cited by 467 · see citing works

Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins

Fisher, E. A. A., & Ginsberg, H. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100068200 · Cited by 459 · see citing works

New insights into the pathophysiology of dyslipidemia in type 2 diabetes

Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works

Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans

Romeo, S., Wu, Y., Kozlitina, J., Pennacchio, L. A., Boerwinkle, E., Hobbs, H. H., & Cohen, J. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37118 · Cited by 422 · see citing works

Angptl3 regulates lipid metabolism in mice

Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., & Furukawa, H. (2002) · Nature Genetics · doi:10.1038/ng814 · Cited by 420 · see citing works

IDIOPATHIC HYPERLIPEMIA: METABOLIC STUDIES IN AN AFFECTED FAMILY*

Havel, R. J., & Gordon, R. S. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104202 · Cited by 380 · see citing works

PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells

Lagace, T. A. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000114 · Cited by 372 · see citing works

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

Johannesen, C. D. L., Mortensen, M. B., Langsted, A., & Nordestgaard, B. G. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.027 · Cited by 359 · see citing works

SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis

Huang, L., Chambliss, K. L., Gao, X., Yuhanna, I. S., Behling‐Kelly, E. L., Bergaya, S., Ahmed, M. H., Michaely, P., Luby‐Phelps, K., Darehshouri, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1140-4 · Cited by 354 · see citing works

Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis

Olofsson, S. ‐., & Borén, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 328 · see citing works

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Borén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · see citing works

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.09.011 · Cited by 319 · see citing works

Apolipoprotein B: mRNA Editing, Lipoprotein Assembly, and Presecretory Degradation

Davidson, N. O., & Shelness, G. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.169 · Cited by 311 · see citing works

Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

Marston, N. A., Giugliano, R. P., Im, K., Silverman, M. G., O’Donoghue, M. L., Wiviott, S. D., Ference, B. A., & Sabatine, M. S. (2019) · Circulation · doi:10.1161/circulationaha.119.041998 · Cited by 301 · see citing works

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

Packard, C. J., Munro, A. F., Lorimer, A. R., Gotto, A. M., & Shepherd, J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111644 · Cited by 298 · see citing works

Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase

Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., Shimizugawa, T., Ando, Y., Koishi, R., Kohama, T., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000252827.51626.89 · Cited by 297 · see citing works

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

Gaudet, D., Karwatowska-Prokopczuk, E., Baum, S. J., Hurh, E., Kingsbury, J., Bartlett, V. J., Figueroa, A. L., Piscitelli, P., Singleton, W., Witztum, J. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa689 · Cited by 279 · see citing works

Contributions of Different Fatty Acid Sources to Very Low-Density Lipoprotein-Triacylglycerol in the Fasted and Fed States

Barrows, B. R., & Parks, E. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1709 · Cited by 273 · see citing works

Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis

Pedersen, S. B., Langsted, A., & Nordestgaard, B. G. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6875 · Cited by 270 · see citing works

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials

Morrone, D., Weintraub, W. S., Toth, P. P., Hanson, M. E., Lowe, R. S., Lin, J., Shah, A. K., & Tershakovec, A. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.016 · Cited by 263 · see citing works

Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

Schneeman, B. O., Kotite, L., Todd, K., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255 · see citing works

Insulin Regulation of Lipoprotein Lipase Activity in 3T3-L1 Adipocytes is Mediated at Posttranscriptional and Posttranslational Levels

Semenkovich, C. F., Wims, M., Noé, L., Étienne, J., & Chan, L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81898-1 · Cited by 249 · see citing works

Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters

Cohn, J. S., Johnson, E. J., Millar, J. S., Cohn, S. D., Milne, R. W., Marcel, Y. L., Russell, R. M., & Schaefer, E. J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35345-1 · Cited by 248 · see citing works

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an "FCS score

Moulin, P., Dufour, R., Averna, M., Arca, M., Cefalù, A. B., Noto, D., D'Erasmo, L., Di Costanzo, A., Marçais, C., Alvarez-Sala Walther, L. A., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.814 · Cited by 247 · see citing works

Genetics of hypertriglyceridemia

Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244 · see citing works

Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis

Lee, M., Saver, J. L., Towfighi, A., Chow, J., & Ovbiagele, B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.020 · Cited by 240 · see citing works

Causes and consequences of hypertriglyceridemia

Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239 · see citing works

Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport

Peterson, J., Bihain, B. E., Bengtsson-Olivecrona, G., Deckelbaum, R. J., Carpentier, Y. A., & Olivecrona, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.909 · Cited by 237 · see citing works

Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.

Borén, J., Lee, I., Zhu, W., Arnold, K. S., Taylor, S., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1847 · Cited by 233 · see citing works

The Interaction of Lipids and Lipoproteins with the Intercellular Matrix of Arterial Tissue: Its Possible Role in Atherogenesis

Camejo, G. (1982) · Advances in lipid research · doi:10.1016/b978-0-12-024919-0.50007-2 · Cited by 231 · see citing works

Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism

Wolska, A., Dunbar, R. L., Freeman, L. A., Ueda, M., Amar, M. J., Sviridov, D. O., & Remaley, A. T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.025 · Cited by 231 · see citing works

Lipoprotein lipase and its regulators: an unfolding story

Wu, S. A., Kersten, S., & Qi, L. (2021) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2020.11.005 · Cited by 225 · see citing works

Severe hypertriglyceridemia is primarily polygenic

Dron, J. S., Wang, J., Cao, H., McIntyre, A. D., Iacocca, M. A., Menard, J. R., Movsesyan, I., Malloy, M. J., Pullinger, C. R., Kane, J. P., et al. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.10.006 · Cited by 222 · see citing works

Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes

Fard, A., Tuck, C. H., Donis, J. A., Sciacca, R. R., Tullio, M. R. D., Wu, H. D., Bryant, T. A., Chen, N.-T., Torres‐Tamayo, M., Ramasamy, R., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2039 · Cited by 221 · see citing works

Angiopoietin-like 3 in lipoprotein metabolism

Kersten, S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.119 · Cited by 220 · see citing works

Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management

Lee, J.-H., & Hegele, R. A. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9665-4 · Cited by 202 · see citing works

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

Adiels, M., Westerbacka, J., Soro‐Paavonen, A., Häkkinen, A. ‐., Vehkavaara, S., CASLAKE, M. J., Packard, C. J., Olofsson, S.-O., Yki‐Järvinen, H., Taskinen, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0790-1 · Cited by 197 · see citing works

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.

Malmström, R., Packard, C. J., CASLAKE, M. J., Bedford, D. K., Stewart, P., Yki‐Järvinen, H., Shepherd, J., & Taskinen, M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.779 · Cited by 197 · see citing works

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196 · see citing works

Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis

Bruckert, E., Labreuche, J., Deplanque, D., Touboul, P.-J., & Amarenco, P. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318202709f · Cited by 192 · see citing works

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

Vallejo-Vaz, A. J., Fayyad, R., Boekholdt, S. M., Hovingh, G. K., Kastelein, J. J., Melamed, S., Barter, P., Waters, D. D., & Ray, K. K. (2018) · Circulation · doi:10.1161/circulationaha.117.032318 · Cited by 187 · see citing works

The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism

Ginsberg, H. N., & Fisher, E. A. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800090-jlr200 · Cited by 184 · see citing works

Postprandial hypertriglyceridemia as a coronary risk factor

Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182 · see citing works

Postprandial metabolism of meal triglyceride in humans

Lambert, J. E., & Parks, E. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.01.006 · Cited by 182 · see citing works

Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men

Malmström, R., Packard, C. J., Watson, T. D. G., Rannikko, S., CASLAKE, M. J., Bedford, D. K., Stewart, P., Yki‐Järvinen, H., Shepherd, J., & Taskinen, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1454 · Cited by 178 · see citing works

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

Balling, M., Afzal, S., Varbo, A., Langsted, A., Davey Smith, G., & Nordestgaard, B. G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.610 · Cited by 175 · see citing works

The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins.

Borén, J., Graham, L., WETTESTEN, M., Scott, J., White, A. L., & Olofsson, S. ‐. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50173-9 · Cited by 172 · see citing works

Postprandial lipoprotein metabolism: VLDL vs chylomicrons

Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 168 · see citing works

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: rationale and design of the STRENGTH trial

Nicholls, S. J., Lincoff, A. M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., Mozaffarian, D., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.23055 · Cited by 167 · see citing works

Inhibition of the Microsomal Triglyceride Transfer Protein Blocks the First Step of Apolipoprotein B Lipoprotein Assembly but Not the Addition of Bulk Core Lipids in the Second Step

Gordon, D. A., Jamil, H., Gregg, R. E., Olofsson, S., & Borén, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33047 · Cited by 165 · see citing works

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia

Hegele, R. A., Berberich, A. J., Ban, M. R., Wang, J., Digenio, A., Alexander, V. J., D'Erasmo, L., Arca, M., Jones, A., Bruckert, E., et al. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.03.093 · Cited by 165 · see citing works

Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.

Wilson, D. E., Emi, M., Iverius, P., Hata, A., Wu, L. L., Hillas, E., Williams, R. R., & Lalouel, J.-M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114770 · Cited by 164 · see citing works

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1589 · Cited by 164 · see citing works

Glucose and Insulin Function through Two Distinct Transcription Factors to Stimulate Expression of Lipogenic Enzyme Genes in Liver

Koo, S., Stoeckman, A. K., & Towle, H. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010029200 · Cited by 160 · see citing works

Mobilisation of enterocyte fat stores by oral glucose in humans

Robertson, M. D., Parkes, M., Warren, B. F., Ferguson, D. J. P., Jackson, K. G., Jewell, D. P., & Frayn, K. N. (2003) · Gut · doi:10.1136/gut.52.6.834 · Cited by 156 · see citing works

Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Gencer, B., Djousse, L., Al-Ramady, O. T., Cook, N. R., Manson, J. E., & Albert, C. M. (2021) · Circulation · doi:10.1161/circulationaha.121.055654 · Cited by 150 · see citing works

Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes

Taskinen, M., & Nikkil�, E. A. (1979) · Diabetologia · doi:10.1007/bf01236268 · Cited by 145 · see citing works

Familial chylomicronemia syndrome: an under‐recognized cause of severe hypertriglyceridaemia

Baass, A., Paquette, M., Bernard, S., & Hegele, R. A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13016 · Cited by 144 · see citing works

Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100

Karpe, F., Bell, M., Björkegren, J., & Hamsten, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.199 · Cited by 143 · see citing works

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Hiukka, A., Ståhlman, M., Pettersson, C., Levin, M. C., Adiels, M., Teneberg, S., Leinonen, E. S., Hultén, L. M., Wiklund, O., Orešič, M., et al. (2009) · Diabetes · doi:10.2337/db09-0206 · Cited by 141 · see citing works

GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

Young, S. G., Fong, L. G., Beigneux, A. P., Allan, C. M., He, C. H., Jiang, H., Nakajima, K., Muthuraman, M., Birrane, G., & Ploug, M. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.023 · Cited by 141 · see citing works

Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis

Schwartz, E. A., & Reaven, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.021 · Cited by 130 · see citing works

The assembly and secretion of apoB 100 containing lipoproteins in Hep G2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly.

Borén, J., WETTESTEN, M., Sjöberg, A., Thorlin, T., Bondjers, G., Wiklund, O., & Olofsson, S. ‐. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86983-6 · Cited by 127 · see citing works

Intestinal lipoprotein assembly

Hussain, M. M., Fatma, S., Pan, X., & Iqbal, J. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169347.53568.5a · Cited by 127 · see citing works

The Microsomal Triglyceride Transfer Protein Catalyzes the Post-translational Assembly of Apolipoprotein B-100 Very Low Density Lipoprotein in McA-RH7777 Cells

Rustaeus, S., Stillemark-Billton, P., Lindberg, K., Gordon, D., & Olofsson, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5196 · Cited by 126 · see citing works

Molecular Mechanism for Changes in Proteoglycan Binding on Compositional Changes of the Core and the Surface of Low-Density Lipoprotein–Containing Human Apolipoprotein B100

Flood, C., Gustafsson, M. V., Pitas, R. E., Arnaboldi, L., Walzem, R. L., & Borén, J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000117174.19078.85 · Cited by 125 · see citing works

Intimal Retention of Cholesterol Derived From Apolipoprotein B100– and Apolipoprotein B48–Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits

Proctor, S. D., & Mamo, J. C. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000084638.14534.0a · Cited by 124 · see citing works

Triacylglycerol hydrolase: role in intracellular lipid metabolism

Dolinsky, V. W., Gilham, D., Alam, M., Vance, D. E., & Lehner, R. S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3426-3 · Cited by 123 · see citing works

Alcohol-induced changes in serum lipoproteins and in their metabolism.

Taskinen, M.-R., Nikkilä, E. A., Välimäki, M., Sane, T., Kuusi, T., Kesäniemi, Y. A., & Ylikahri, R. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90614-4 · Cited by 122 · see citing works

GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production

Hein, G. J., Baker, C., Hsieh, J., Farr, S., & Adeli, K. (2012) · Diabetes · doi:10.2337/db12-0202 · Cited by 121 · see citing works

A Comprehensive Update on the Chylomicronemia Syndrome

Goldberg, R. B., & Chait, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.593931 · Cited by 121 · see citing works

Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion

Gilham, D., Ho, S. B., Rasouli, M., Martres, P., Vance, D. E., & Lehner, R. S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0728fje · Cited by 115 · see citing works

Systemic and Forearm Triglyceride Metabolism

Miles, J. M., Park, Y., Walewicz, D., Russell-Lopez, C., Windsor, S. L., Isley, W. L., Coppack, S. W., & Harris, W. S. (2004) · Diabetes · doi:10.2337/diabetes.53.3.521 · Cited by 114 · see citing works

Genetic and Developmental Regulation of the Lipoprotein Lipase Gene: Loci Both Distal and Proximal to the Lipoprotein Lipase Structural Gene Control Enzyme Expression

Kirchgessner, T. G., LeBoeuf, R. C., Langner, C., Zollman, S., Chang, C., Taylor, B. A., Schotz, M. C., Gordon, J. I., & Lusis, A. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94212-2 · Cited by 113 · see citing works

Oro-sensory perception of dietary lipids: new insights into the fat taste transduction

Khan, N. A., & Besnard, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.001 · Cited by 111 · see citing works

Receptor-Mediated ER Export of Lipoproteins Controls Lipid Homeostasis in Mice and Humans

Wang, X., Wang, H., Xu, B., Huang, D., Nie, C., Pu, L., Zajac, G. J. M., Yan, H., Zhao, J., Shi, F., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.020 · Cited by 111 · see citing works

The Diagnosis and Treatment of Hypertriglyceridemia

Parhofer, K. G., & Laufs, U. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0825 · Cited by 110 · see citing works

Dynamics of fat absorption and effect of sham feeding on postprandial lipema

Chavez–Jauregui, R. N., Mattes, R. D., & Parks, E. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.002 · Cited by 109 · see citing works

Identification of the Proteoglycan Binding Site in Apolipoprotein B48

Flood, C., Gustafsson, M. V., Richardson, P. E., Harvey, S. C., Segrest, J. P., & Borén, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204053200 · Cited by 107 · see citing works

Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms

Xiao, C., Stahel, P., & Lewis, G. F. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.015 · Cited by 107 · see citing works

32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT

Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E. A. A., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(11)70033-2 · Cited by 105 · see citing works

Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes

Kanter, J. E., Shao, B., Kramer, F., Barnhart, S., Shimizu‐Albergine, M., Vaisar, T., Graham, M. J., Crooke, R. M., Manuel, C. R., Haeusler, R. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127308 · Cited by 105 · see citing works

Insulin Acutely Inhibits Intestinal Lipoprotein Secretion in Humans in Part by Suppressing Plasma Free Fatty Acids

Pavlic, M., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2009) · Diabetes · doi:10.2337/db09-1297 · Cited by 102 · see citing works

FoxO1 and hepatic lipid metabolism

Sparks, J. D., & Dong, H. H. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b3f4c · Cited by 96 · see citing works

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

Hiukka, A., Fruchart‐Najib, J., Leinonen, E. S., Hilden, H., Fruchart, J., & Taskinen, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1753-z · Cited by 96 · see citing works

Effects of ethanol intake on lipoproteins and atherosclerosis.

Brinton, E. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833c1f41 · Cited by 95 · see citing works

Determinants of VLDL-triglycerides production

Nielsen, S., & Karpe, F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283544956 · Cited by 94 · see citing works

New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk

Kersten, S. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000600 · Cited by 94 · see citing works

A new dawn for managing dyslipidemias: The era of rna-based therapies

Macchi, C., Sirtori, C. R., Corsini, A., Santos, R. D., Watts, G. F., & Ruscica, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104413 · Cited by 94 · see citing works

Molecular mechanisms of apolipoprotein B mRNA editing

Anant, S., & Davidson, N. O. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00009 · Cited by 91 · see citing works

Influence of triacylglycerol biosynthesis rate on the assembly of apoB-100-containing lipoproteins in Hep G2 cells.

Borén, J., Rustaeus, S., WETTESTEN, M., Andersson, M., Wiklund, A., & Olofsson, S. ‐. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1743 · Cited by 88 · see citing works

Remnant lipoproteins: are they equal to or more atherogenic than LDL?

Salinas, C. A. A., & Chapman, M. J. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000682 · Cited by 87 · see citing works

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

Doi, T., Langsted, A., & Nordestgaard, B. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab555 · Cited by 87 · see citing works

Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics

Julve, J., Martín-Campos, J. M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.004 · Cited by 85 · see citing works

ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition

Chen, Y., Pottanat, T. G., Zhen, Y., Siegel, R. W., Ehsani, M. E., Qian, Y., & Konrad, R. J. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100068 · Cited by 85 · see citing works

Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

Sigfrids, F. J., Dahlström, E. H., Forsblom, C. M., Sandholm, N., Harjutsalo, V., Taskinen, M., & Groop, P. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13298 · Cited by 85 · see citing works

Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia

Tremblay, A. J., Lamarche, B., Cohn, J. S., Hogue, J., & Couture, P. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000216750.09611.ec · Cited by 84 · see citing works

Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin

Haridas, P. A. N., Soronen, J., Sädevirta, S., Mysore, R., Quagliarini, F., Pasternack, A. H., Metso, J., Perttilä, J., Leivonen, M., Smas, C. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1254 · Cited by 83 · see citing works

Triglycerides and cardiovascular disease

Esan, O., & Wierzbicki, A. S. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000862 · Cited by 83 · see citing works

Exome-wide association study of plasma lipids in > 300,000 individuals

Liu, D. J., Peloso, G. M., Yu, H., Butterworth, A. S., Wang, X., Mahajan, A., Saleheen, D., Emdin, C. A., Alam, D. S., Alves, A. C., et al. (2017) · Figshare · Cited by 82 · see citing works

Carbohydrate quality changes and concurrent changes in cardiovascular risk factors: a longitudinal analysis in the PREDIMED-Plus randomized trial

Martínez‐González, M. Á., Fernandez-Lazaro, C. I., Toledo, E., Díaz‐López, A., Corella, D., Goday, A., Romaguera, D., Vioqué, J., Alonso‐Gómez, Á. M., Wärnberǵ, J., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz298 · Cited by 82 · see citing works

Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans

Borén, J., Adiels, M., Björnson, E., Matikainen, N., Söderlund, S., Rämö, J., Ståhlman, M., Ripatti, P., Ripatti, S., Palotie, A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.144079 · Cited by 81 · see citing works

Apolipoprotein B metabolism in homozygous familial hypercholesterolemia.

James, R. W., Martin, B., Pometta, D., Fruchart, J., Duriez, P., Puchois, P., Farriaux, J. P., Tacquet, A., Demant, T., & Clegg, R. J. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38378-4 · Cited by 79 · see citing works

Recent advances in triacylglycerol mobilization by the gut

Xiao, C., Stahel, P., Carreiro, A. L., Buhman, K. K., & Lewis, G. F. (2018) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2017.12.001 · Cited by 77 · see citing works

The Assembly and Secretion of Apolipoprotein B-48-containing Very Low Density Lipoproteins in McA-RH7777 Cells

Stillemark-Billton, P., Borén, J., Andersson, M., Larsson, T. P., Rustaeus, S., Karlsson, K., & Olofsson, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10506 · Cited by 76 · see citing works

Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus

Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Sberna, A.-L., Petit, J.-M., Degrace, P., & Demizieux, L. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.310990 · Cited by 75 · see citing works

Acute Hyperinsulinemia Decreases the Hepatic Secretion of Very-Low-Density Lipoprotein Apolipoprotein B-100 in NIDDM

Cummings, M. H., Watts, G. F., Umpleby, A. M., Hennessy, T. R., Kelly, J. M., Jackson, N. C., & Sönksen, P. H. (1995) · Diabetes · doi:10.2337/diab.44.9.1059 · Cited by 74 · see citing works

Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins

Gaw, A. J., Packard, C. J., Lindsay, G. M., Griffin, B. A., CASLAKE, M. J., Lorimer, A. R., & Shepherd, J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39764-9 · Cited by 73 · see citing works

Lipid Lowering Drugs: Present Status and Future Developments

Ruscica, M., Ferri, N., Santos, R. D., Sirtori, C. R., & Corsini, A. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00918-3 · Cited by 73 · see citing works

Apolipoprotein B Secretory Regulation by Degradation

Olofsson, S., & Borén, J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251116 · Cited by 69 · see citing works

Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes

D’Erasmo, L., Costanzo, A. D., Cassandra, F., Minicocci, I., Polito, L., Montali, A., Ceci, F., & Arca, M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313401 · Cited by 69 · see citing works

A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides

Wolska, A. T., Lo, L., Sviridov, D. O., Pourmousa, M., Pryor, M., Ghosh, S. S., Kakkar, R. K., Davidson, M., Wilson, S. R., Pastor, R. W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7905 · Cited by 69 · see citing works

Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue

Ruppert, P. M. M., Michielsen, C. C. J. R., Hazebroek, E. J., Pirayesh, A., Olivecrona, G., Afman, L. A., & Kersten, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101033 · Cited by 69 · see citing works

Lipid Binding of Apolipoprotein CII Is Required for Stimulation of Lipoprotein Lipase Activity Against Apolipoprotein CII–Deficient Chylomicrons

Olivecrona, G., & Beisiegel†, U. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.8.1545 · Cited by 68 · see citing works

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Hiukka, A., Leinonen, E., Jauhiainen, M., Sundvall, J., Ehnholm, C., Keech, A. C., & Taskinen, M. R. (2007) · Diabetologia · doi:10.1007/s00125-007-0751-8 · Cited by 68 · see citing works

Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity

Adiels, M., Matikainen, N., Westerbacka, J., Söderlund, S., Larsson, T. P., Olofsson, S., Borén, J., & Taskinen, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.001 · Cited by 68 · see citing works

Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation

Fischer, A. W., Jaeckstein, M. Y., Gottschling, K., Heine, M., Sass, F., Mangels, N., Schlein, C., Worthmann, A., Bruns†, O. T., Yuan, Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.001 · Cited by 67 · see citing works

Oral Fat Exposure Increases the First Phase Triacylglycerol Concentration Due to Release of Stored Lipid in Humans

Mattes, R. D. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3656 · Cited by 65 · see citing works

Body Mass Index, Triglycerides, and Risk of Acute Pancreatitis: A Population-Based Study of 118 000 Individuals

Hansen, S. E. J., Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz059 · Cited by 64 · see citing works

The pathophysiology of intestinal lipoprotein production

Giammanco, A., Cefalu, A. B., Noto, D., & Averna, M. R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00061 · Cited by 61 · see citing works

RNA-targeted therapeutics for lipid disorders

Tsimikas, S. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000549 · Cited by 61 · see citing works

Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans

Xiao, C., Pavlic, M., Szeto, L., Patterson, B. W., & Lewis, G. F. (2010) · Diabetes · doi:10.2337/db10-0763 · Cited by 60 · see citing works

Triglycerides and residual risk

Vallejo‐Vaz, A. J., Corral, P., Schreier, L. E., & Ray, K. K. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000530 · Cited by 60 · see citing works

Genetic Variants Associated With Increased Plasma Levels of Triglycerides, via Effects on the Lipoprotein Lipase Pathway, Increase Risk of Acute Pancreatitis

Hansen, S. E. J., Madsen, C. M., Varbo, A., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.016 · Cited by 59 · see citing works

Sortilin as a Regulator of Lipoprotein Metabolism

Strong, A., & Rader, D. J. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0248-x · Cited by 57 · see citing works

Ethanol with a mixed meal increases postprandial triacylglycerol but decreases postprandial non-esterified fatty acid concentrations

Fielding, B. A., Grady, G. R. M., Humphreys, S. M., Evans, K., & Frayn, K. N. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500000763 · Cited by 57 · see citing works

Intracellular events in the assembly of chylomicrons in rabbit enterocytes

Cartwright, I. J., Plonné, D., & Higgins, J. A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31966-0 · Cited by 57 · see citing works

Greater enrichment of triacylglycerol-rich lipoproteins with apolipoproteins E and C-III after meals rich in saturated fatty acids than after meals rich in unsaturated fatty acids1–3

Jackson, K. G., Wolstencroft, E. J., Bateman, P. A., Yaqoob, P., & Williams, C. M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.25 · Cited by 56 · see citing works

Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin

Pieke, B., von Eckardstein, A., Gülbahçe, E., Chirazi, A., Schulte, H., Assmann, G., & Wahrburg, U. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801440 · Cited by 55 · see citing works

Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia

Adiels, M., Taskinen, M., Björnson, E., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Hakkarainen, A., Lundbom, N., Sihlbom, C., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13744 · Cited by 55 · see citing works

Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics

Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12877 · Cited by 54 · see citing works

Apolipoprotein C-II: the re-emergence of a forgotten factor

Wolska, A. T., Reimund, M., & Remaley, A. T. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000680 · Cited by 54 · see citing works

Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: Do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials

Casula, M., Olmastroni, E., Gazzotti, M., Galimberti, F., Zambon, A., & Catapano, A. L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105060 · Cited by 54 · see citing works

Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis

Blom, D. J., Raal, F. J., Santos, R. D., & Marais, A. D. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0809-3 · Cited by 51 · see citing works

Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans

Mattes, R. D. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90591.2008 · Cited by 50 · see citing works

ROLE OF LIPID SYNTHESIS, CHAPERONE PROTEINS AND PROTEASOMES IN THE ASSEMBLY AND SECRETION OF APOPROTEIN B‐CONTAINING LIPOPROTEINS FROM CULTURED LIVER CELLS

Ginsberg, H. N. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb03051.x · Cited by 47 · see citing works

Oral Glucose Mobilizes Triglyceride Stores From the Human Intestine

Xiao, C., Stahel, P., Carreiro, A. L., Hung, Y.-H., Dash, S., Bookman, I. D., Buhman, K. K., & Lewis, G. F. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.002 · Cited by 46 · see citing works

Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects

Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Hakkarainen, A., Lundbom, N., Lundbom, J., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13017 · Cited by 46 · see citing works

Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

Ahmed, O., Littmann, K., Gustafsson, U. O., Pramfalk, C., Öörni, K., Larsson, L., Minniti, M. E., Sahlin, S., Camejo, G., Parini, P., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009876 · Cited by 45 · see citing works

Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment

Gallo, A., Béliard, S., D’Erasmo, L., & Bruckert, É. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00885-1 · Cited by 44 · see citing works

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease

Dai, W., Zhang, Z., Yao, C., & Zhao, S. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1166-5 · Cited by 43 · see citing works

Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase

Liu, H., Talmud, P. J., Lins, L., Brasseur, R., Olivecrona, G., Peelman, F., Vandekerckhove, J. S., Rosseneu, M., & Labeur, C. (2000) · Biochemistry · doi:10.1021/bi0009441 · Cited by 42 · see citing works

Regulation of human apolipoprotein B gene expression at multiple levels

Wang, A., Liu, D., & Liang, C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00313-6 · Cited by 42 · see citing works

Transport of LDLs into the arterial wall: impact in atherosclerosis

Zhang, X., & Fernandez-Hernando, C. F. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000701 · Cited by 41 · see citing works

Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes

Taskinen, M., Björnson, E., Matikainen, N., Söderlund, S., Pietiläinen, K. H., Ainola, M., Hakkarainen, A., Lundbom, N., Fuchs, J., Thorsell, A., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14328 · Cited by 40 · see citing works

Role of the Gut in Diabetic Dyslipidemia

Stahel, P., Xiao, C., Nahmias, A., & Lewis, G. F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00116 · Cited by 39 · see citing works

Insights into incretin-based therapies for treatment of diabetic dyslipidemia

Stemmer, K., Finan, B., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.008 · Cited by 39 · see citing works

Genetics of hypertriglyceridemia and atherosclerosis

Gill, P. K., Dron, J. S., & Hegele, R. A. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000839 · Cited by 39 · see citing works

The angiopoietin-like protein 3

Arca, M., Minicocci, I., & Maranghi, M. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283630cf0 · Cited by 37 · see citing works

Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans

Prinsen, B. H. C. M. T., Romijn, J. A., Bisschop, P. H. L. T., de Barse, M. M. J., Barrett, P. H. R., Ackermans, M. T., Berger, R., Rabelink, T. J., & der Velden, M. G. M. D. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300023-jlr200 · Cited by 37 · see citing works

The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?

Reeskamp, L. F., Tromp, T. R., & Stroes, E. S. G. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000679 · Cited by 37 · see citing works

Physical State of Lipids and Foreign Substances Producing Atherosclerosis

Moreton, J. R. (1948) · Science · doi:10.1126/science.107.2780.371 · Cited by 36 · see citing works

Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism

Chan, D. C., Watts, G. F., Somaratne, R. M., Wasserman, S. M., Scott, R. C., & Barrett, P. H. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310882 · Cited by 36 · see citing works

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

Björnson, E., Adiels, M., Taskinen, M.-R., Burgess, S., Rawshani, A., Borén, J., & Packard, C. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad337 · Cited by 183 · see citing works

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease

Li, Z., Zhang, B., Liu, Q., Tao, Z., Ding, L., Guo, B., Zhang, E., Zhang, H., Meng, Z., Guo, S., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104543 · Cited by 137 · see citing works

Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

Zhao, Y., Zhuang, Z., Li, Y., Xiao, W., Song, Z., Huang, N., Wang, W., Dong, X., Jia, J., Clarke, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46686-x · Cited by 117 · see citing works

Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy

Xu, H., She, P., Zhao, Z., Ma, B., Li, G., & Wang, Y. (2023) · Advanced Materials · doi:10.1002/adma.202300439 · Cited by 99 · see citing works

Apolipoprotein B-containing lipoproteins in atherogenesis

Borén, J., Packard, C. J., & Binder, C. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01111-0 · Cited by 104 · see citing works

Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population

Sheng, G., Kuang, M., Yang, R., Zhong, Y., Zhang, S., & Zou, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03470-z · Cited by 86 · see citing works

VLDL Biogenesis and Secretion: It Takes a Village

Zwol, W. H.-V., van de Sluis, B., Ginsberg, H. N., & Kuivenhoven, J. A. (2024) · Circulation Research · doi:10.1161/circresaha.123.323284 · Cited by 83 · see citing works

Lipids dysregulation in diseases: core concepts, targets and treatment strategies

Dakal, T. C., Xiao, F., Bhusal, C. K., Sabapathy, P. C., Segal, R., Chen, J., & Bai, X. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-024-02425-1 · Cited by 82 · see citing works

Understanding the cause of type 2 diabetes

Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 83 · see citing works

The potential cardiometabolic effects of long-chain ω-3 polyunsaturated fatty acids: recent updates and controversies

Bae, J. H., Lim, H., & Lim, S. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.03.014 · Cited by 78 · see citing works

Triglyceride-rich lipoproteins and cardiovascular diseases

Xu, D., Xie, L., Cheng, C., Xue, F., & Sun, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409653 · Cited by 73 · see citing works

Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients

Li, T., Wang, P., Wang, X., Liu, Z., Zhang, Z., Zhang, Y., Wang, Z., Feng, Y., Wang, Q., Guo, X., et al. (2023) · Nutrients · doi:10.3390/nu15122808 · Cited by 71 · see citing works

Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux

Gugliucci, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134399 · Cited by 65 · see citing works

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 65 · see citing works

Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study

Wang, Z., Chen, J., Zhu, L., Jiao, S., Chen, Y., & Sun, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03567-3 · Cited by 58 · see citing works

Target Populations for Novel Triglyceride-Lowering Therapies

Nordestgaard, A. T., Tybjærg-Hansen, A., Mansbach, H., Kersten, S., Nordestgaard, B. G., & Rosenson, R. S. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.02.035 · Cited by 54 · see citing works

Highly Valuable Fish Oil: Formation Process, Enrichment, Subsequent Utilization, and Storage of Eicosapentaenoic Acid Ethyl Esters

Yi, M., You, Y., Zhang, Y., Wu, G., Karrar, E. M. A., Zhang, L., Zhang, H., Jin, Q., & Wang, X. (2023) · Molecules · doi:10.3390/molecules28020672 · Cited by 52 · see citing works

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment

Wang, K., Wang, R., Yang, J., Liu, X., Shen, H., Sun, Y., Zhou, Y., Fang, Z. A., & Ge, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.913869 · Cited by 49 · see citing works

Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives

Li, X., Xie, E., Sun, S., Shen, J., Ding, Y., Wang, J., Peng, X., Zheng, R., Farag, M. A. F., & Xiao, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.014 · Cited by 46 · see citing works

Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease

Ganda, O. P. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000875 · Cited by 42 · see citing works

The chylomicron saga: time to focus on postprandial metabolism

Gugliucci, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1322869 · Cited by 41 · see citing works

HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome

Alcover, S., Ramos-Regalado, L., Girón, G., Muñoz‐García, N., & Vilahur, G. (2025) · Antioxidants · doi:10.3390/antiox14040434 · Cited by 45 · see citing works

Non-invasive lipid panel of MASLD fibrosis transition underscores the role of lipoprotein sulfatides in hepatic immunomodulation

Lam, S. M., Wang, Z., Song, J., Shi, Y., Liu, W., Wan, L., Duan, K., Chua, G. H., Zhou, Y., Wang, G., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.009 · Cited by 39 · see citing works

Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies

Tessier, A., Wang, F., Liang, L., Wittenbecher, C., Haslam, D. E., Eliassen, A. H., Tobias, D. K., Li, J., Zeleznik, O. A., Ascherio, A., et al. (2024) · Med · doi:10.1016/j.medj.2024.01.010 · Cited by 37 · see citing works

Biosynthesis and Metabolism of ApoB-Containing Lipoproteins

Borén, J., Taskinen, M., & Packard, C. J. (2024) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062222-020716 · Cited by 43 · see citing works

Discordant High Remnant Cholesterol With LDL-C Increases the Risk of Stroke: A Chinese Prospective Cohort Study

Han, M., Huang, K., Shen, C., Hu, H., Liu, F., Li, J., Yang, X., Chen, J.-C., Liu, X., Cao, J., et al. (2024) · Stroke · doi:10.1161/strokeaha.124.046811 · Cited by 35 · see citing works

Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics

Liu, Y., Li, C., Yang, X. P., Yang, B. T., & Fu, Q. (2024) · Biomaterials Science · doi:10.1039/d4bm00415a · Cited by 30 · see citing works

Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know

Chapman, M. J., Packard, C. J., Björnson, E., Ginsberg, H. N., & Borén, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120529 · Cited by 32 · see citing works

Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials

Elías-López, D., Doi, T., Nordestgaard, B. G., & Kobylecki, C. J. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000999 · Cited by 29 · see citing works

[Incisional hernia after surgery for abdominal aortic aneurysm].

Augestad, K. M., Wilsgaard, T., & Solberg, S. K. (2002) · PubMed · Cited by 29 · see citing works

The Cardioprotective Effects of Polyunsaturated Fatty Acids Depends on the Balance Between Their Anti- and Pro-Oxidative Properties

Sidorkiewicz, M. (2024) · Nutrients · doi:10.3390/nu16223937 · Cited by 28 · see citing works

Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors

Gallo, A., Goff, W. L., Santos, R. D., Fichtner, I., Carugo, S., Corsini, A., Sirtori, C. R., & Ruscica, M. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14326 · Cited by 26 · see citing works

Causal cardiovascular risk factors for dementia: insights from observational and genetic studies

Kjeldsen, E. W., & Frikke‐Schmidt, R. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae235 · Cited by 28 · see citing works

The Influence of Physical Exercise, Ketogenic Diet, and Time-Restricted Eating on De Novo Lipogenesis: A Narrative Review

Paoli, A. (2025) · Nutrients · doi:10.3390/nu17040663 · Cited by 26 · see citing works

The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications

Akivis, Y., Alkaissi, H. R., McFarlane, S. I., & Bukharovich, I. F. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x272750240109052319 · Cited by 29 · see citing works

Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease

Li, X., Li, Z.-F., & Wu, N. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25985 · Cited by 26 · see citing works

The lipidomic correlates of epigenetic aging across the adult lifespan: A population‐based study

Liu, D., Aziz, N. A., Landstra, E. N., & Breteler, M. M. B. (2023) · Aging Cell · doi:10.1111/acel.13934 · Cited by 23 · see citing works

The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?

Tramontano, D., D'Erasmo, L., Larouche, M., Brisson, D., Lauzière, A., Di Costanzo, A., Bini, S., Minicocci, I., Covino, S., Baratta, F., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119146 · Cited by 23 · see citing works

New insights into foam cells in atherosclerosis

Ai, J., Tang, X., Zhou, Y., Mao, B., Zhang, Q., Zhao, J., Chen, W., & Cui, S. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf202 · Cited by 23 · see citing works

The Novel Role of Metabolism-Associated Molecular Patterns in Sepsis

Zhu, X.-X., Zhang, W.-W., Wu, C., Wang, S.-S., Smith, F. G., Jin, S., & Zhang, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.915099 · Cited by 23 · see citing works

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy

Taskinen, M., Matikainen, N., Björnson, E., Söderlund, S., Inkeri, J., Hakkarainen, A., Parviainen, H., Sihlbom, C., Thorsell, A., Andersson, L. K., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06008-0 · Cited by 23 · see citing works

Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population

Liu, S., Zhang, D., Ju, J., Wang, A., Du, T., Chen, X., Song, Y., Gao, Z., & Xu, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1260764 · Cited by 23 · see citing works

ANGPTL3/8 is an atypical unfoldase that regulates intravascular lipolysis by catalyzing unfolding of lipoprotein lipase

Kumari, A., Larsen, S. W. R., Bondesen, S., Qian, Y., Tian, H., Walker, S. G., Davies, B. S. J., Remaley, A. T., Young, S. G., Konrad, R. J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2420721122 · Cited by 20 · see citing works

Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study

Li, Z., Yu, C., Zhang, H., Chen, R., Zhao, Y., & Zheng, Z. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02537-z · Cited by 20 · see citing works

Using a Metabotype Framework to Deliver Personalized Nutrition Improves Dietary Quality and Metabolic Health Parameters: A 12‐Week Randomized Controlled Trial

Hillesheim, E., Yin, X., Sundaramoorthy, G. P., & Brennan, L. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200620 · Cited by 20 · see citing works

6-PPD triggered lipid metabolism disorder and inflammatory response in larval zebrafish (Danio rerio) by regulating PPARγ/NF-κB pathway

Qian, Q., Wu, J., Wang, C., Yang, Z., Cheng, Y., Zheng, Y., Wang, X., & Wang, H. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.125785 · Cited by 19 · see citing works

Unexpected omega-3 activities in intracellular lipolysis and macrophage foaming revealed by fluorescence lifetime imaging

Tang, H., Liu, Z., Han, G., Geng, J., Liu, B., Zhang, R., & Zhang, Z. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321255121 · Cited by 19 · see citing works

Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes

Elías-López, D., Wadström, B. N., Vedel‐Krogh, S., Kobylecki, C. J., & Nordestgaard, B. G. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01555-1 · Cited by 18 · see citing works

Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke

Li, H., Ke, X., Feng, B., Tian, H., Cai, Z., Zhang, A., & Man, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1500650 · Cited by 18 · see citing works

Triglycerides, Triglyceride-Rich Lipoproteins, and Remnant Cholesterol in Atherosclerotic Cardiovascular Disease

Jo, S. (2025) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2025.14.3.247 · Cited by 19 · see citing works

Sugar and Dyslipidemia: A Double-Hit, Perfect Storm

Gugliucci, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175660 · Cited by 18 · see citing works

Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding

Sarkar, S. K., Matyas, A., Asikhia, I., Hu, Z., Golder, M., Beehler, K., Kosenko, T., & Lagace, T. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.960272 · Cited by 17 · see citing works

SLC16A7 Promotes Triglyceride Deposition by De Novo Lipogenesis in Chicken Muscle Tissue

Wang, Y., Liu, L., Liu, X., Tan, X., Zhu, Y., Luo, N., Zhao, G., Cui, H., & Wen, J. (2022) · Biology · doi:10.3390/biology11111547 · Cited by 17 · see citing works

Effects of sn-2 Palmitic Triacylglycerols and the Ratio of OPL to OPO in Human Milk Fat Substitute on Metabolic Regulation in Sprague-Dawley Rats

Zhu, L., Fang, S., Zhang, Y., Sun, X., Yang, P., Lu, W., & Yu, L. L. (2024) · Nutrients · doi:10.3390/nu16091299 · Cited by 17 · see citing works

Association of low-grade inflammation and elevated remnant cholesterol with risk of ASCVD and mortality in impaired renal function

Elías-López, D., Kobylecki, C. J., Vedel‐Krogh, S., Doi, T., & Nordestgaard, B. G. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119241 · Cited by 16 · see citing works

Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis

Pintó, X., Fanlo‐Maresma, M., Esteve, V., Millán, J., Blanco, A., Blasco, M., Díaz-Díaz, J. L., Rodríguez, Á. D., Mangas, A., Pascual, V., et al. (2023) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2023.02.001 · Cited by 18 · see citing works

Chaiqin chengqi decoction treatment mitigates hypertriglyceridemia-associated acute pancreatitis by modulating liver-mediated glycerophospholipid metabolism

Wen, Y., Li, Y., Liu, T., Huang, L., Yao, L., Deng, D., Luo, W., Cai, W., Zhong, S., Jin, T., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155968 · Cited by 16 · see citing works

Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention

Gonçalves, M., Costa, M., Paiva‐Martins, F., & Silva, P. (2024) · Molecules · doi:10.3390/molecules29204841 · Cited by 16 · see citing works

The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation

Smith, K., Dennis, K. M. J. H., & Hodson, L. (2025) · Experimental Physiology · doi:10.1113/ep092001 · Cited by 17 · see citing works

How ANGPTL3 Inhibition Will Help Our Clinical Practice?

Bini, S., Tramontano, D., Minicocci, I., Costanzo, A. D., Tambaro, F., D’Erasmo, L., & Arca, M. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01076-w · Cited by 15 · see citing works

Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism

Wen, Y., Chen, Y., & Konrad, R. J. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000910 · Cited by 15 · see citing works

Endothelial force sensing signals to parenchymal cells to regulate bile and plasma lipids

Lichtenstein, L., Cheng, C. W., Bajarwan, M., Evans, E. L., Gaunt, H. J., Bartoli, F., Chuntharpursat-Bon, E., Patel, S., Konstantinou, C., Futers, T. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq3075 · Cited by 15 · see citing works

Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum

Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01880-6 · Cited by 14 · see citing works

Effects of Dietary Plant-Derived Low-Ratio Linoleic Acid/Alpha-Linolenic Acid on Blood Lipid Profiles: A Systematic Review and Meta-Analysis

Wang, Q., Zhang, H., Jin, Q., & Wang, X. (2023) · Foods · doi:10.3390/foods12163005 · Cited by 14 · see citing works

Bone controls browning of white adipose tissue and protects from diet-induced obesity through Schnurri-3-regulated SLIT2 secretion

Li, Z., Shi, B., Li, N., Sun, J., Zeng, X., Huang, R., Bok, S., Chen, X., Han, J., Yallowitz, A. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51155-6 · Cited by 14 · see citing works

Association between the atherogenic index of plasma and the systemic immuno-inflammatory index using NHANES data from 2005 to 2018

Li, J., Hou, D., Li, J., Li, R., & Sun, M. Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-96090-8 · Cited by 17 · see citing works

Diversity of extracellular vesicle sources in atherosclerosis: role and therapeutic application

Zhang, Y., Zhang, W., Wu, Z., & Chen, Y. (2025) · Angiogenesis · doi:10.1007/s10456-025-09983-7 · Cited by 14 · see citing works

Manno‐oligosaccharides from Cassia Seed Gum Attenuate Atherosclerosis through Inflammation Modulation and Intestinal Barrier Integrity Improvement in ApoE −/− Mice

Li, J., Zhen, H., Yang, S., Yan, Q., & Jiang, Z. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300187 · Cited by 13 · see citing works

Hypertriglyceridemia: molecular and genetic landscapes

Scicchitano, P., Amati, F., Ciccone, M. M., D’Ascenzi, F., Imbalzano, E., Liga, R., Paolillo, S., Pastore, M. C., Rinaldi, A., Mattioli, A. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126364 · Cited by 13 · see citing works

Traditional Chinese medicine and plant-derived natural products in regulating triglyceride metabolism: Mechanisms and therapeutic potential

Zhou, J., & Wang, X. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107387 · Cited by 13 · see citing works

Effects of Small-Sided Soccer Games on Physical Fitness and Cardiometabolic Health Biomarkers in Untrained Children and Adolescents: A Systematic Review and Meta-Analysis

Gómez-Álvarez, N., Boppre, G., Hermosilla-Palma, F. A., Reyes-Amigo, T., de Oliveira, J. J. F., & Fonseca, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175221 · Cited by 13 · see citing works

Rab2A-mediated Golgi-lipid droplet interactions support very-low-density lipoprotein secretion in hepatocytes

Xu, M., Chen, Z., Li, Y., Li, Y., Ge, G., Dai, R.-Z., Ni, N., Tao, J., Wang, H., Chen, Q., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00288-x · Cited by 13 · see citing works

Antioxidant Peptides from the Fruit Source of the Oil Crop Litsea cubeba Ameliorate FFA-Induced Oxidative Stress Injury: Based on Nrf2/Keap1 Pathway and Molecular Dynamics Simulations

Li, L., Hu, Y. M., Wang, Y., Wu, X.-X., Lin, S.-T., Li, H., Zhang, J., Fan, G., Wang, Z., Wang, B., et al. (2025) · Foods · doi:10.3390/foods14101707 · Cited by 12 · see citing works

Overexpression of NgBR inhibits high-fat diet–induced atherosclerosis in ApoE-deficiency mice

Gong, K., Wang, M., Wang, D., Gao, Y., Ma, L., Yang, X., Zhu, X., Chen, S., Zhang, M., Li, H., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000048 · Cited by 12 · see citing works

Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development

Yang, X., Weber, A. A., Mennillo, E., Secrest, P., Chang, M. W., Wong, S., Le, S., Liu, J., Benner, C. W., Karin, M., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp12381 · Cited by 12 · see citing works

The biogenesis and transport of triglyceride-rich lipoproteins

Zhang, L., Wang, X., & Chen, X. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.015 · Cited by 12 · see citing works

Akkermansia Muciniphila supplementation improves hyperlipidemia, cardiac function, and gut microbiota in high fat fed apolipoprotein E–deficient mice

Xiao, X., Wu, Y., Jie, Z., Lü, L., Li, Y., Hu, W. H., Li, Y. M., & Zhong, S. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106906 · Cited by 13 · see citing works

Polysaccharide from Caulerpa lentillifera alleviates hyperlipidaemia through altering bile acid metabolism mediated by gut microbiota

Long, H., Huang, R., Zhu, S., Wang, Z., Liu, X., & Zhu, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141663 · Cited by 12 · see citing works

Combined action of albumin and heparin regulates lipoprotein lipase oligomerization, stability, and ligand interactions

Risti, R., Gunn, K. H., Hiis-Hommuk, K., Seeba, N.-N., Karimi, H., Villo, L., Vendelin, M., Neher, S. B., & Lõokene, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283358 · Cited by 12 · see citing works

Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease

Rehman, M. B., Björnson, E., Adiels, M., Morze, J., Bergström, G. M. L., Gummesson, A., Erlinge, D., Fall, T., Matic, L. P., Söderberg, S., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehaf1124 · Cited by 11 · see citing works

Mitochondrial Homeostasis in Obesity-related Hypertriglyceridemia

Mela, V., Ruiz‐Limón, P., Balongo, M., Rad, H. M., Subiri-Verdugo, A., Gonzalez-Jimenez, A., Soler, R., Ocaña, L., el Azzouzi, H., Tinahones, F. J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac332 · Cited by 11 · see citing works

Causal Associations of Environmental Pollution and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study

Gao, H., Li, J., Ma, Q., Zhang, Q., Li, M., & Hu, X. (2024) · Global Heart · doi:10.5334/gh.1331 · Cited by 11 · see citing works

Genetic association of lipid traits and lipid-related drug targets with normal tension glaucoma: a Mendelian randomization study for predictive preventive and personalized medicine

Kang, T., Zhou, Y., Fan, C., Zhang, Y., Yu, Y., & Jiang, J. C. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00373-5 · Cited by 11 · see citing works

Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease

Borén, J., Packard, C. J., Nordestgaard, B. G., & Catapano, A. L. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf214 · Cited by 12 · see citing works

Effect of the Dual Glucose‐Dependent Insulinotropic Peptide/Gulcagon‐like Peptide 1 Receptor Agonist Tirzepatide on Lipid Profile and Waist Circumference: A Systematic Review and Meta‐analysis

Yu, D., Shen, S., Zhang, J., & Wang, Q. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.06.008 · Cited by 11 · see citing works

Remnant cholesterol, vascular risk, and prevention of atherosclerosis

Pintó, X., Fanlo‐Maresma, M., Esteve-Luque, V., & Millán, J. (2023) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2023.07.005 · Cited by 12 · see citing works

Metabolomic aging clock predicts risk of different cardiovascular diseases in the UK Biobank

You, G., Wang, K., Shen, R., Chen, X., Jiang, J., Sun, Y., Wu, D., Xu, J., Huang, K., & Yao, C. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156467 · Cited by 12 · see citing works

Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies

Gugliucci, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175229 · Cited by 10 · see citing works

Cross-ancestry analyses of Chinese and European populations reveal insights into the genetic architecture and disease implication of metabolites

Lin, C., Xia, M., Dai, Y., Huang, Q., Sun, Z., Zhang, G., Luo, R., Peng, Q., Li, J., Wang, X., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100810 · Cited by 11 · see citing works

A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study

Alcala-Diaz, J. F., Larriva, A. P. A.-D., Torres-Peña, J. D., Rodríguez-Cantalejo, F., Rangel-Zúñiga, O. A., Yubero‐Serrano, E. M., Gutierrez-Mariscal, F. M., Cardelo, M. P., Luque, R. M., Ordovás, J. M., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.885256 · Cited by 10 · see citing works

Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits

Park, J. K., Bafna, S., Forrest, I. S., Duffy, Á., Márquez‐Luna, C., Petrazzini, B. O., Vy, H. M. T., Jordan, D. M., Verbanck, M., Narula, J., et al. (2023) · eLife · doi:10.7554/elife.80560 · Cited by 9 · see citing works

Short‐Term Statin Therapy Induces Hepatic Insulin Resistance Through HNF4 α /PAQR9/PPM1 α Axis Regulated AKT Phosphorylation

Lin, Y., Wang, S., Li, Z., Zhou, Y., Wang, R., Wang, Y., & Chen, Y. (2024) · Advanced Science · doi:10.1002/advs.202403451 · Cited by 8 · see citing works

The Level of Remnant Cholesterol and Implications for Lipid-Lowering Strategy in Hospitalized Patients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China—Acute Coronary Syndrome Project

Yang, N., Wang, M., Liu, J., Liu, J., Hao, Y., Zhao, D., & on behalf of CCC-ACS Investigators (2022) · Metabolites · doi:10.3390/metabo12100898 · Cited by 9 · see citing works

Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals

Johansen, M. Ø., Moreno‐Vedia, J., Balling, M., Smith, G. D., & Nordestgaard, B. G. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117316 · Cited by 9 · see citing works

Genetics of remnant cholesterol

Wulff, A. B., & Nordestgaard, B. G. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000991 · Cited by 8 · see citing works

Remnant cholesterol, high-sensitivity C-reactive protein, and risk of incident coronary heart disease among patients with chronic kidney disease based on UK biobank

Han, M., Zhou, J., Wan, Z., Chen, M., Yan, M., Feng, W. S., Wang, G., Zhang, J., Zhang, L., Yan, L., et al. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00982-5 · Cited by 8 · see citing works

Triglyceride-based lipotoxicity in the pathophysiology of chronic diseases

Liu, J., Fan, X., Song, Y., & Zhao, J. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.07.004 · Cited by 8 · see citing works

Effects of Mannan Oligosaccharides on Growth, Antioxidant and Immune Performance, and mTOR Signaling Pathway in Juvenile Tilapia (Oreochromis niloticus)

Zhang, Q., Li, L. X., Ma, Z., He, W., Huang, E., Meng, L., Li, L., Tong, T., Yang, H., Liu, Y., et al. (2025) · Animals · doi:10.3390/ani15162459 · Cited by 8 · see citing works

Non-coding RNAs in lipid metabolism and their roles in atherosclerosis

Sallam, T., Solingen, C. V., & Moore, K. J. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01229-9 · Cited by 8 · see citing works

Substantial Lipid Increases During Menopausal Transition in Korean Middle-Aged Women

Park, J., Son, M. K., & Park, H. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e238 · Cited by 8 · see citing works

Metabolism of Triglyceride-Rich Lipoproteins

Borén, J., & Taskinen, M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_520 · Cited by 22 · see citing works

Triglyceride-Rich Lipoproteins

Kockx, M., & Kritharides, L. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.008 · Cited by 18 · see citing works

ApoB-Containing Lipoprotein Particles as Risk Factors for Coronary Artery Disease

Alaupovic, P., Blackenhorn, D. H., Knight‐Gibson, C., Tavella, M. J., Bard, J., Shafer, D., Lee, E. T., & Brasuell, J. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5904-3_36 · Cited by 15 · see citing works

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196 · see citing works

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.

Mj, M., & Jp, K. (2001) · PubMed · Cited by 141 · see citing works